Oral treatments for outpatient COVID-19: Effectiveness and value.

Beinfeld, Molly; Yeung, Kai; Whittington, Melanie D; Mohammed, Rasheed; Nhan, Emily; Pearson, Steven D

Beinfeld, Molly; Yeung, Kai; Whittington, Melanie D; Mohammed, Rasheed; Nhan, Emily; Pearson, Steven D.

Afiliación

Beinfeld M; Institute for Clinical and Economic Review, Boston, MA.
Yeung K; Kaiser Permanente Washington Health Research Institute, Seattle.
Whittington MD; Institute for Clinical and Economic Review, Boston, MA.
Mohammed R; Institute for Clinical and Economic Review, Boston, MA.
Nhan E; Institute for Clinical and Economic Review, Boston, MA.
Pearson SD; Institute for Clinical and Economic Review, Boston, MA.

J Manag Care Spec Pharm ; 28(8): 903-909, 2022 Aug.

Article en En | MEDLINE | ID: mdl-35876296

Asunto(s)

COVID-19; Pacientes Ambulatorios; Análisis Costo-Beneficio; Humanos; Massachusetts; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pacientes Ambulatorios / COVID-19 Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Manag Care Spec Pharm Año: 2022 Tipo del documento: Article País de afiliación: Marruecos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google